D. Goodkin

J. Bragg-Gresham, F. Port, A. Lopes, 2010, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

Target haematocrit during erythropoietin therapy.

A. Nissenson, A. Besarab, W. K. Bolton, 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

R. Wolfe, J. Bragg-Gresham, F. Port, 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Enhanced Training in Vascular Access Creation Predicts Arteriovenous Fistula Placement and Patency in Hemodialysis Patients: Results From the Dialysis Outcomes and Practice Patterns Study

B. Gillespie, R. Merion, T. Akiba, 2008, Annals of surgery.

Prevalence, incidence, and risk factors for hepatitis C virus infection in hemodialysis patients.

M. Jadoul, T. Akiba, R. Pisoni, 2019, Kidney international.

An Outpatient Maneuver to Treat Bloody Effluent during Continuous Ambulatory Peritoneal Dialysis (CAPD)

D. Goodkin, Mary G. Benning, 1990, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Massive adrenocortical carcinoma presenting as peripheral edema: a case report

D. Goodkin, 2022, Journal of Medical Case Reports.

Data from the Dialysis Outcomes and Practice Patterns Study validate an association between high intravenous iron doses and mortality.

F. Locatelli, G. Bailie, M. Inaba, 2015, Kidney international.

Mortality, Hospitalization, and Quality of Life among Patients with Hepatitis C Infection on Hemodialysis.

M. Jadoul, R. Pisoni, D. Goodkin, 2017, Clinical journal of the American Society of Nephrology : CJASN.

The normal hematocrit study--follow-up.

A. Nissenson, A. Besarab, D. Goodkin, 2008, The New England journal of medicine.

Hepatitis C Infection Is Very Rarely Treated among Hemodialysis Patients

M. Jadoul, B. Gillespie, D. Goodkin, 2013, American Journal of Nephrology.

Mortality among hemodialysis patients in Europe, Japan, and the United States: case-mix effects.

N. Levin, E. Young, D. Goodkin, 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Intravenous versus subcutaneous dosing of epoetin alfa in hemodialysis patients.

J. Egrie, S. Graber, J. Lazarus, 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

The Normal Haematocrit Trial in dialysis patients with cardiac disease.

A. Nissenson, A. Besarab, W. K. Bolton, 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Effects of Epoetin Alfa on Hemostasis in Chronic Renal Failure

D. Goodkin, Winson W. Tang, R. Stead, 1998, American Journal of Nephrology.

Blood Pressure Levels and Mortality Risk among Hemodialysis Patients: Results from the Dialysis Outcomes and Practice Patterns Study

H. Morgenstern, S. Fukuhara, R. Wolfe, 2014 .

Prospective study of the immune effects of normalizing the hemoglobin concentration in hemodialysis patients who receive recombinant human erythropoietin.

W. K. Bolton, P. Lobo, D. Goodkin, 2004, Journal of the American Society of Nephrology : JASN.

Radiographic contrast medium--induced glossitis.

D. Goodkin, 1985, Archives of internal medicine.

Iron and calciphylaxis.

M. Larkina, D. Goodkin, B. Robinson, 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

The role of the anion gap in detecting and managing mixed metabolic acid-base disorders.

R. Narins, D. Goodkin, G. G. Krishna, 1984, Clinics in endocrinology and metabolism.

The Calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism.

W. Goodman, J. Coburn, R. Cohen, 2002, Journal of the American Society of Nephrology : JASN.

A calcimimetic agent lowers plasma parathyroid hormone levels in patients with secondary hyperparathyroidism.

W. Liu, W. Goodman, J. Coburn, 2000, Kidney international.

The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin.

A R Nissenson, A. Nissenson, J. Egrie, 1998, The New England journal of medicine.

Nonadherence in hemodialysis: associations with mortality, hospitalization, and practice patterns in the DOPPS.

S. Fukuhara, J. Bragg-Gresham, F. Port, 2003, Kidney international.

Pharmacologic and cytokine treatment of commonly encountered anemias.

D. Goodkin, M. Foote, A. Colowick, 2002, Cytokines, cellular & molecular therapy.

Blood pressure levels and mortality risk among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study.

H. Morgenstern, S. Fukuhara, R. Wolfe, 2012, Kidney international.

Burial at sea.

D. Goodkin, 2007, The Pharos of Alpha Omega Alpha-Honor Medical Society. Alpha Omega Alpha.

The Dialysis Outcomes and Practice Patterns Study (DOPPS): How Can We Improve the Care of Hemodialysis Patients?

D. Mapes, P. Held, D. Goodkin, 2001, Seminars in dialysis.

Variation in intravenous iron use internationally and over time: the Dialysis Outcomes and Practice Patterns Study (DOPPS).

F. Locatelli, G. Bailie, Yun Li, 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Intravenous iron dose and mortality in hemodialysis patients.

G. Bailie, D. Goodkin, 2015, Kidney international.

Mechanisms of bromocriptine-induced hallucinations.

D. Goodkin, 1980, The New England journal of medicine.

Mortality risk in hemodialysis patients and changes in nutritional indicators: DOPPS.

F. Port, P. Held, B. Maroni, 2002, Kidney international.

Kidney transplantation and wait-listing rates from the international Dialysis Outcomes and Practice Patterns Study (DOPPS).

S. Fukuhara, R. Wolfe, R. Merion, 2005, Kidney international.

Creation, cannulation and survival of arteriovenous fistulae: data from the Dialysis Outcomes and Practice Patterns Study.

B. Gillespie, F. Port, T. Akiba, 2003, Kidney international.

Body mass index and mortality in 'healthier' as compared with 'sicker' haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS).

F. Port, E. Young, D. Goodkin, 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Association of predialysis serum bicarbonate levels with risk of mortality and hospitalization in the Dialysis Outcomes and Practice Patterns Study (DOPPS).

F. Locatelli, F. Port, T. Akiba, 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Vascular access use in Europe and the United States: results from the DOPPS.

R. Wolfe, B. Gillespie, D. Dykstra, 2002, Kidney international.

Potassium-Binding Resins: Associations with Serum Chemistries and Interdialytic Weight Gain in Hemodialysis Patients

M. Jadoul, F. Tentori, A. Karaboyas, 2014, American Journal of Nephrology.

Mortality and hospitalization in haemodialysis patients in five European countries: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS).

R. Wolfe, H. Feldman, F. Locatelli, 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

International variation in vitamin prescription and association with mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS).

J. Bragg-Gresham, B. Gillespie, F. Port, 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

The burden of amputation among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS).

S. Fukuhara, M. Jadoul, J. Bragg-Gresham, 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Rosiglitazone is associated with mortality in chronic hemodialysis patients.

R. Wolfe, F. Port, G. Bailie, 2009, Journal of the American Society of Nephrology : JASN.

Hematocrit stability following intravenous versus subcutaneous administration of epoetin alfa to dialysis patients: a post hoc analysis.

J. Egrie, S. Graber, D. Goodkin, 1999, Clinical Nephrology.

Resistance to Erythropoiesis-Stimulating Agents among Patients on Hemodialysis Is Typically Transient

M. Nangaku, A. Karaboyas, A. Cases, 2022, American Journal of Nephrology.

Absence of Anemia in Hemodialysis Patients

R. Pisoni, D. Goodkin, D. Fuller, 2011, Blood Purification.

Role of platelet‐derived growth factor in osteoblast function and bone synthesis

G. Pierce, D. Goodkin, 1993, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

SAFETY OF RENAL BIOPSY

D. Goodkin, 1983, The Lancet.

International prevalence of hepatitis C positivity among hemodialysis patients awaiting transplantation.

D. Goodkin, B. Bieber, 2018, Kidney international.

Venous access: are women equal?

F. Port, D. Goodkin, 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Iron and calciphylaxis.

M. Larkina, D. Goodkin, Bruce M. Robinson, 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.